• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续因呼吸困难住院的心力衰竭患者的超声心动图亚型。

Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea.

机构信息

Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark.

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.

出版信息

Open Heart. 2019 Jun 20;6(1):e000928. doi: 10.1136/openhrt-2018-000928. eCollection 2019.

DOI:10.1136/openhrt-2018-000928
PMID:31297224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6593198/
Abstract

UNLABELLED

Heart failure with preserved ejection fraction (HFpEF) involves half of hospitalised patients with heart failure (HF), but estimates vary due to unclear diagnostic criteria. We performed a prospective observational study of hospitalised patients admitted with dyspnoea. The aim was to apply contemporary guidelines to diagnose HF due to valvular disease (HFvhd), HF due to reduced ejection fraction (HFrEF), HF due to midrange EF (HFmrEF) and HFpEF in relation to presumed cardiac or non-cardiac dyspnoea.

METHODS

We included consecutive hospitalised patients with presumed HF or dyspnoea and excluded patients with acute coronary syndrome, estimated glomerular filtration rate <30 mL/min/1.73 m² or low NT-proBNP (<296 ng/L). Higher age-adjusted NT-proBNP values excluded patients with presumptive non-cardiac dyspnoea. Contemporary criteria for HFpEF and diastolic dysfunction were assessed, and we adjudicated whether acute decompensated HF (ADHF) had been the primary diagnosis.

RESULTS

Of 707 eligible patients, we included 370 patients of whom 75 had non-cardiac dyspnoea. Of these, 10% (38/370) had no cardiac dysfunction. Cardiac dysfunction consisted of 18.4%, HFvhd, 30.1% HFrEF, 10.2% HFmrEF and 41.3% HFpEF. HFpEF was twice as common in presumptive non-cardiac dyspnoea versus cardiac dyspnoea (71% vs 34%, p<0.0001). However, adjudicated ADHF was the primary diagnosis in 80% of HFrEF, 62% of HFmrEF and just 28% of HFpEF.

CONCLUSION

HF according to contemporary criteria applied to 90% of patients admitted with dyspnoea and elevated NT-proBNP irrespective of the presumptive cause of dyspnoea, of whom 10% had HFmrEF and 41% HFpEF. However, significant non-cardiac diagnoses related to 9 out of 10 with HFpEF with pulmonary disease as the predominant adjudicated problem.

摘要

目的

应用当代指南诊断因瓣膜病(HFvhd)、射血分数降低的心力衰竭(HFrEF)、中间射血分数的心力衰竭(HFmrEF)和心力衰竭伴有保留射血分数(HFpEF)导致的呼吸困难住院患者,并评估呼吸困难的假定心脏或非心脏病因。

方法

我们纳入了因疑似心力衰竭或呼吸困难而住院的连续患者,并排除了急性冠状动脉综合征、估计肾小球滤过率 <30 mL/min/1.73 m² 或低 NT-proBNP(<296 ng/L)的患者。较高的年龄调整后 NT-proBNP 值排除了有非心脏性呼吸困难假定的患者。评估了 HFpEF 和舒张功能障碍的当代标准,并判断急性失代偿性心力衰竭 (ADHF) 是否为主要诊断。

结果

在 707 名合格患者中,我们纳入了 370 名患者,其中 75 名有非心脏性呼吸困难。在这些患者中,10%(38/370)没有心脏功能障碍。心脏功能障碍包括 18.4%的 HFvhd、30.1%的 HFrEF、10.2%的 HFmrEF 和 41.3%的 HFpEF。HFpEF 在假定非心脏性呼吸困难患者中是假定心脏性呼吸困难患者的两倍(71%比 34%,p<0.0001)。然而,ADHF 是 HFrEF、HFmrEF 中 62%和 HFpEF 中仅 28%患者的主要诊断。

结论

根据当代标准,90%因呼吸困难和升高的 NT-proBNP 而住院的患者被诊断为心力衰竭,无论呼吸困难的假定病因如何,其中 10%有 HFmrEF 和 41%有 HFpEF。然而,与 10 例 HFpEF 相关的 9 例有重要的非心脏性诊断,以肺病为主要判断问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/2ddf3aa61e69/openhrt-2018-000928f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/bdba8d1cc7c1/openhrt-2018-000928f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/ab8efb0ed540/openhrt-2018-000928f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/5d1cf5189b32/openhrt-2018-000928f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/2ddf3aa61e69/openhrt-2018-000928f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/bdba8d1cc7c1/openhrt-2018-000928f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/ab8efb0ed540/openhrt-2018-000928f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/5d1cf5189b32/openhrt-2018-000928f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bec/6593198/2ddf3aa61e69/openhrt-2018-000928f04.jpg

相似文献

1
Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea.连续因呼吸困难住院的心力衰竭患者的超声心动图亚型。
Open Heart. 2019 Jun 20;6(1):e000928. doi: 10.1136/openhrt-2018-000928. eCollection 2019.
2
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].[中国实际临床实践中住院心力衰竭患者的当代流行病学与治疗]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):865-874. doi: 10.3760/cma.j.issn.0253-3758.2019.11.004.
3
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.射血分数保留、中间范围和降低的心衰患者的非心脏性与心脏性死亡率。
J Am Heart Assoc. 2019 Oct 15;8(20):e013441. doi: 10.1161/JAHA.119.013441. Epub 2019 Oct 5.
4
Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.根据射血分数评估新发和急性失代偿性心力衰竭患者的结局。
Heart. 2018 Mar;104(6):525-532. doi: 10.1136/heartjnl-2017-311813. Epub 2017 Oct 5.
5
Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.日本住院心力衰竭患者射血分数保留、中间范围和降低的临床特征。
ESC Heart Fail. 2019 Jun;6(3):475-486. doi: 10.1002/ehf2.12418. Epub 2019 Mar 3.
6
Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.在一项前瞻性国际多民族队列研究中,射血分数保留型与射血分数降低型心力衰竭相关的死亡率。
Eur Heart J. 2018 May 21;39(20):1770-1780. doi: 10.1093/eurheartj/ehy005.
7
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.N 端脑利钠肽前体在射血分数保留型、中间范围型和降低型心力衰竭中的相关性及其预后和鉴别诊断作用。
J Card Fail. 2018 Jun;24(6):365-374. doi: 10.1016/j.cardfail.2018.03.010. Epub 2018 Mar 27.
8
Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.急性失代偿性心力衰竭伴射血分数保留和降低时表现出相当的血液动力学充血。
Eur J Heart Fail. 2018 Apr;20(4):738-747. doi: 10.1002/ejhf.1050. Epub 2017 Dec 18.
9
Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: an analysis from the Korean Heart Failure (KorHF) Registry.肾功能与左心室收缩功能及N末端B型利钠肽原水平的关系及其在射血分数保留与降低的心力衰竭中的预后意义:来自韩国心力衰竭(KorHF)注册研究的分析
Korean Circ J. 2017 Sep;47(5):727-741. doi: 10.4070/kcj.2017.0050. Epub 2017 Aug 16.
10
Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.利用 NT-proBNP 筛选和富集 HFpEF、HFmrEF 和 HFrEF 临床试验的入组患者。
JACC Heart Fail. 2018 Mar;6(3):246-256. doi: 10.1016/j.jchf.2017.12.014. Epub 2018 Feb 7.

引用本文的文献

1
Palliative Care in Acute Heart Failure.急性心力衰竭的姑息治疗。
Curr Heart Fail Rep. 2020 Dec;17(6):424-437. doi: 10.1007/s11897-020-00494-8. Epub 2020 Oct 29.

本文引用的文献

1
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.急性心力衰竭中在标准治疗基础上加用重组人松弛素:RELAX-AHF-2研究的理论依据与设计
Eur J Heart Fail. 2017 Jun;19(6):800-809. doi: 10.1002/ejhf.830. Epub 2017 Apr 28.
2
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.乌利那肽对急性心力衰竭患者心血管死亡率的影响。
N Engl J Med. 2017 May 18;376(20):1956-1964. doi: 10.1056/NEJMoa1601895. Epub 2017 Apr 12.
3
Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults: The Atherosclerosis Risk in Communities Study.
老年人左心室舒张功能的当代评估:社区动脉粥样硬化风险研究
Circulation. 2017 Jan 31;135(5):426-439. doi: 10.1161/CIRCULATIONAHA.116.024825. Epub 2016 Dec 7.
4
Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting.与西方人群相比,在亚洲人群中,N 末端脑利钠肽前体对急性失代偿性心力衰竭的诊断具有更好的性能。
Eur J Heart Fail. 2017 Feb;19(2):209-217. doi: 10.1002/ejhf.612. Epub 2016 Sep 13.
5
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图评估左心室舒张功能的建议:美国超声心动图学会和欧洲心血管影像学会的更新
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360. doi: 10.1093/ehjci/jew082. Epub 2016 Jul 15.
6
Reframing the association and significance of co-morbidities in heart failure.重新构建心力衰竭共病的关联和意义。
Eur J Heart Fail. 2016 Jul;18(7):744-58. doi: 10.1002/ejhf.600. Epub 2016 Jun 30.
7
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
8
Targeting Comorbidities in Elderly Patients With Heart Failure: The OPTIMIZE-HFPEF Trial.针对老年心力衰竭患者的合并症:OPTIMIZE-HFPEF试验
J Card Fail. 2016 Jul;22(7):545-7. doi: 10.1016/j.cardfail.2016.03.002. Epub 2016 Mar 7.
9
Optimizing the Management of Heart Failure With Preserved Ejection Fraction in the Elderly by Targeting Comorbidities (OPTIMIZE-HFPEF).通过针对合并症优化老年射血分数保留的心力衰竭管理(OPTIMIZE-HFPEF)。
J Card Fail. 2016 Jul;22(7):539-44. doi: 10.1016/j.cardfail.2016.01.011. Epub 2016 Jan 25.
10
Heart failure with preserved ejection fraction: uncertainties and dilemmas.射血分数保留的心力衰竭:不确定性和困境。
Eur J Heart Fail. 2015 Jul;17(7):665-71. doi: 10.1002/ejhf.304. Epub 2015 Jun 16.